- Home
- ABEO vs EIC Comparison
ABEO vs EIC Comparison
Compare ABEO & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | EIC |
|---|---|---|
| Founded | 1974 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 223.3M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | EIC |
|---|---|---|
| Price | $4.88 | $9.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $20.00 | $12.63 |
| AVG Volume (30 Days) | ★ 1.4M | 140.3K |
| Earning Date | 05-14-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 14.07% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | ★ $4.76 | $9.08 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $3.97 | $9.17 |
| 52 Week High | $7.54 | $14.80 |
Technical Indicators
Market Signals| Indicator | ABEO | EIC |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 47.94 |
| Support Level | $4.53 | $9.25 |
| Resistance Level | $5.62 | $10.15 |
| Average True Range (ATR) | 0.18 | 0.18 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 83.33 | 87.50 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.